Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oncogenic and tumor-suppressive roles of Lipocalin 2 (LCN2) in tumor progression

19 Jul 2024

Abstract excerpt

. LCN2 is significantly expressed in various tumors and plays an important role in regulating tumor cell proliferation, invasion, and metastasis. The specific actions of LCN2 in tumors may vary depending on the particular type of cancer involved. In this review, we provide an extensive overview of the transcriptional and post-transcriptional regulation of LCN2 in health and disease. Furthermore, we summarize the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Kidney Injury Research
Share to Anesthesia and Neurotoxicity Research
Share to Electrolyte and hormonal disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40109857
DOI: 10.32604/or.2024.051672

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oncogenic and tumor-suppressive roles of Lipocalin 2 (LCN2) in tumor progressionPMID 40109857Read ↗

LCN2: Versatile players in breast cancerSemantic proximity Read ↗

Lipocalin 2 promotes breast cancer progression.Semantic proximity Read ↗

Lipocalin-2 negatively regulates epithelial–mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancerSemantic proximity Read ↗

Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transitionSemantic proximity Read ↗

Lipocalin-2 Inhibits Osteosarcoma Cell Metastasis by Suppressing MET Expression via the MEK–ERK PathwaySemantic proximity Read ↗

Lipocalin 2: A multifaceted modulator of human cancerSemantic proximity Read ↗

An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor MicroenvironmentSemantic proximity Read ↗

Implication and role of neutrophil gelatinase-associated lipocalin in cancer: lipocalin-2 as a potential novel emerging comprehensive therapeutic target for a variety of cancer typesSemantic proximity Read ↗

Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic markerSemantic proximity Read ↗

Knockdown of lipocalin‐2 suppresses the growth and invasion of prostate cancer cellsSemantic proximity Read ↗

Perspectives in Lipocalin-2: Emerging Biomarker for Medical Diagnosis and Prognosis for Alzheimer's DiseaseSemantic proximity Read ↗

HIC1 silencing in triple-negative breast cancer drives progression through misregulation of LCN2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.